You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 104 No. 6, June 1986 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  CLINICAL SCIENCES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (58)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Onchocerciasis

The Ocular Effects of Ivermectin and Diethylcarbamazine

Hugh R. Taylor, MD; Robert P. Murphy, MD; Henry S. Newland, FRACS; Albert T. White, MD; Salvatore A. D'Anna; Ezatollah Keyvan-Larijani, MD; Mohammed A. Aziz, MD; Edward W. Cupp, PhD; Bruce M. Greene, MD

Arch Ophthalmol. 1986;104(6):863-870.


Abstract



• The ocular changes that occur with diethylcarbamazine treatment of onchocerciasis seriously restrict its usefulness. Ivermectin, a newly developed antifilarial drug, was compared with diethylcarbamazine for treatment of onchocerciasis in a double-masked, placebo-controlled trial. Thirty men with moderate to severe infection and ocular involvement were randomly assigned to receive ivermectin as a single oral dose (200 µg/kg), diethylcarbamzine (administered for eight days), or placebo. Detailed ocular examinations were performed serially over a 12-month period. Diethylcarbamazine treatment caused a marked increase in living and dead microfilariae in the cornea, punctate opacities, and limbitis during the first week of therapy. lvermectin had no such effect. However, ivermectin therapy resulted in a long-term reduction in intraocular microfilariae comparable to that seen with diethylcarbamazine. Ivermectin appears to have few ocular complications and be a better-tolerated and more effective microfilaricidal agent than diethylcarbamazine for the treatment of onchocerciasis.



Author Affiliations



From the Ocular Onchocerciasis Research Unit, Dana Center for Preventive Ophthalmology, The Wilmer Institute, The Johns Hopkins University, Baltimore (Drs Taylor, Murphy, Newland, and Keyvan-Larijani and Mr D'Anna); the Department of Medicine, Case Western Reserve University and University Hospitals, Cleveland (Drs White and Greene); Merck Sharpe & Dohme Research Laboratories, Rahway, NJ (Dr Aziz); and the Department of Entomology, Cornell University, Ithaca, NY (Dr Cupp).


Footnotes



Accepted for publication Dec 6, 1985.

Reprint requests to The Wilmer Institute, The Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD 21205 (Dr Taylor).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Onchocerciasis in New York City: The Moa-Manhattan Connection
Encarnacion et al.
Arch Intern Med 1994;154:1749-1751.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.